Search

Phirin Sam

Examiner (ID: 17194, Phone: (571)272-3082 , Office: P/2476 )

Most Active Art Unit
2476
Art Unit(s)
2619, 2661, 2476, 2616, 2732, 2419
Total Applications
1835
Issued Applications
1538
Pending Applications
185
Abandoned Applications
138

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6655775 [patent_doc_number] => 20030077639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Ribozyme mediated inactivation of the androgen receptor' [patent_app_type] => new [patent_app_number] => 10/246078 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 18583 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077639.pdf [firstpage_image] =>[orig_patent_app_number] => 10246078 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/246078
Ribozyme mediated inactivation of the androgen receptor Sep 16, 2002 Issued
Array ( [id] => 6817682 [patent_doc_number] => 20030068640 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders' [patent_app_type] => new [patent_app_number] => 10/244633 [patent_app_country] => US [patent_app_date] => 2002-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 29543 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068640.pdf [firstpage_image] =>[orig_patent_app_number] => 10244633 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/244633
Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders Sep 16, 2002 Abandoned
Array ( [id] => 6831614 [patent_doc_number] => 20030182672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Genetic silencing' [patent_app_type] => new [patent_app_number] => 10/245805 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 35676 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20030182672.pdf [firstpage_image] =>[orig_patent_app_number] => 10245805 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/245805
Genetic silencing Sep 15, 2002 Abandoned
Array ( [id] => 7134574 [patent_doc_number] => 20040043386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Methods and compositions for functional ubiquitin assays' [patent_app_type] => new [patent_app_number] => 10/232951 [patent_app_country] => US [patent_app_date] => 2002-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 26307 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043386.pdf [firstpage_image] =>[orig_patent_app_number] => 10232951 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/232951
Methods and compositions for functional ubiquitin assays Aug 29, 2002 Abandoned
Array ( [id] => 837134 [patent_doc_number] => 07393950 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-01 [patent_title] => 'Antisense oligonucleotides targeted to human CDC45' [patent_app_type] => utility [patent_app_number] => 10/232923 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 12974 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/393/07393950.pdf [firstpage_image] =>[orig_patent_app_number] => 10232923 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/232923
Antisense oligonucleotides targeted to human CDC45 Aug 28, 2002 Issued
Array ( [id] => 7208500 [patent_doc_number] => 20050053580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Use of microbiology non-viral substances for treating acne' [patent_app_type] => utility [patent_app_number] => 10/487618 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5470 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053580.pdf [firstpage_image] =>[orig_patent_app_number] => 10487618 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/487618
Use of microbiology non-viral substances for treating acne Aug 22, 2002 Abandoned
Array ( [id] => 6797076 [patent_doc_number] => 20030175950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'RNA interference mediated inhibition of HIV gene expression using short interfering RNA' [patent_app_type] => new [patent_app_number] => 10/225023 [patent_app_country] => US [patent_app_date] => 2002-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 38604 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175950.pdf [firstpage_image] =>[orig_patent_app_number] => 10225023 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/225023
RNA interference mediated inhibition of HIV gene expression using short interfering RNA Aug 20, 2002 Abandoned
Array ( [id] => 6851529 [patent_doc_number] => 20030143732 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNA' [patent_app_type] => new [patent_app_number] => 10/224005 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 35328 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143732.pdf [firstpage_image] =>[orig_patent_app_number] => 10224005 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/224005
RNA interference mediated inhibition of adenosine A1 receptor (ADORA1) gene expression using short interfering RNA Aug 19, 2002 Abandoned
Array ( [id] => 6829686 [patent_doc_number] => 20030180744 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'High affinity oligonucleotide ligands to growth factors' [patent_app_type] => new [patent_app_number] => 10/223666 [patent_app_country] => US [patent_app_date] => 2002-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 32832 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180744.pdf [firstpage_image] =>[orig_patent_app_number] => 10223666 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/223666
High affinity oligonucleotide ligands to growth factors Aug 18, 2002 Abandoned
Array ( [id] => 326436 [patent_doc_number] => 07514207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Methods of screening for compounds that decrease phosphorylation of merlin and may be useful in cancer treatment' [patent_app_type] => utility [patent_app_number] => 10/486750 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 14 [patent_no_of_words] => 13585 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514207.pdf [firstpage_image] =>[orig_patent_app_number] => 10486750 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/486750
Methods of screening for compounds that decrease phosphorylation of merlin and may be useful in cancer treatment Aug 12, 2002 Issued
Array ( [id] => 803193 [patent_doc_number] => 07422896 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-09 [patent_title] => 'Compositions for DNA mediated gene silencing' [patent_app_type] => utility [patent_app_number] => 10/217564 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26085 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 217 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/422/07422896.pdf [firstpage_image] =>[orig_patent_app_number] => 10217564 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/217564
Compositions for DNA mediated gene silencing Aug 11, 2002 Issued
Array ( [id] => 733475 [patent_doc_number] => 07038036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-02 [patent_title] => 'Oligonucleotides labeled with stable isotopes and a method for detecting the same' [patent_app_type] => utility [patent_app_number] => 10/214503 [patent_app_country] => US [patent_app_date] => 2002-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4756 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 355 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/038/07038036.pdf [firstpage_image] =>[orig_patent_app_number] => 10214503 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/214503
Oligonucleotides labeled with stable isotopes and a method for detecting the same Aug 6, 2002 Issued
Array ( [id] => 6652946 [patent_doc_number] => 20030008808 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Antibacterial and antiviral agents and methods of screening for the same' [patent_app_type] => new [patent_app_number] => 10/212905 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6721 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008808.pdf [firstpage_image] =>[orig_patent_app_number] => 10212905 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/212905
Antibacterial and antiviral agents and methods of screening for the same Aug 5, 2002 Issued
Array ( [id] => 7357863 [patent_doc_number] => 20040014049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Antisense modulation of protein kinase C-iota expression' [patent_app_type] => new [patent_app_number] => 10/199674 [patent_app_country] => US [patent_app_date] => 2002-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30710 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014049.pdf [firstpage_image] =>[orig_patent_app_number] => 10199674 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/199674
Antisense modulation of protein kinase C-iota expression Jul 18, 2002 Abandoned
Array ( [id] => 7361833 [patent_doc_number] => 20040014699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Antisense modulation of PTPRM expression' [patent_app_type] => new [patent_app_number] => 10/200293 [patent_app_country] => US [patent_app_date] => 2002-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30365 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014699.pdf [firstpage_image] =>[orig_patent_app_number] => 10200293 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/200293
Antisense modulation of PTPRM expression Jul 17, 2002 Abandoned
Array ( [id] => 6815132 [patent_doc_number] => 20030074682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Isolation, characterization, and use of a novel teleost potassium channel' [patent_app_type] => new [patent_app_number] => 10/193692 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12737 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20030074682.pdf [firstpage_image] =>[orig_patent_app_number] => 10193692 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/193692
Isolation, characterization, and use of a novel teleost potassium channel Jul 10, 2002 Abandoned
Array ( [id] => 6725522 [patent_doc_number] => 20030207834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Oligonucleotide-containing pharmacological compositions and their use' [patent_app_type] => new [patent_app_number] => 10/191997 [patent_app_country] => US [patent_app_date] => 2002-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19318 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207834.pdf [firstpage_image] =>[orig_patent_app_number] => 10191997 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/191997
Oligonucleotide-containing pharmacological compositions and their use Jul 9, 2002 Abandoned
Array ( [id] => 6913182 [patent_doc_number] => 20050176940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Aptamers and antiaptamers' [patent_app_type] => utility [patent_app_number] => 10/482006 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11726 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176940.pdf [firstpage_image] =>[orig_patent_app_number] => 10482006 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/482006
Aptamers and antiaptamers Jun 27, 2002 Abandoned
Array ( [id] => 6687933 [patent_doc_number] => 20030031658 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Targeting of endosomal growth factor processing as anti-cancer therapy' [patent_app_type] => new [patent_app_number] => 10/170219 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7178 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031658.pdf [firstpage_image] =>[orig_patent_app_number] => 10170219 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/170219
Targeting of endosomal growth factor processing as anti-cancer therapy Jun 11, 2002 Abandoned
Array ( [id] => 6702376 [patent_doc_number] => 20030225256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Antisense modulation of pctaire protein kinase 2 expression' [patent_app_type] => new [patent_app_number] => 10/160787 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30165 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20030225256.pdf [firstpage_image] =>[orig_patent_app_number] => 10160787 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/160787
Antisense modulation of pctaire protein kinase 2 expression May 30, 2002 Abandoned
Menu